⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5365742 | 1.00 | — | — | |
| SCHEMBL7954391 | 1.00 | — | — | |
| Acetic Acid SCHEMBL4434338 | 0.87 | ALDH1A1 (0.44) | — | |
| SCHEMBL14609298 | 0.72 | — | — | |
| SCHEMBL351265 | 0.72 | — | — | |
| SCHEMBL351266 | 0.72 | — | — | |
| SCHEMBL14038538 | 0.70 | — | — | |
| SCHEMBL27902544 | 0.70 | — | — | |
| SCHEMBL153615 | 0.69 | — | — | |
| SCHEMBL5889011 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1847 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240306688-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | claimed |
| EP-4391827-A1 | METHOD OF MITIGATING OFF-ODORS | Givaudan SA (CH) | 2024-07-03 | — | — | EP | claimed |
| WO-2023025549-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2023-03-02 | — | — | WO | claimed |
| CN-112076187-B | Application of android ingot in preparation of medicine for preventing or treating non-alcoholic fatty liver disease | 善笙生物科技股份有限公司 | 2022-04-08 | — | — | CN | claimed |
| EP-0989973-B1 | CHALCONES HAVING ANTIPROLIFERATIVE ACTIVITY | INDENA SPA (IT) | 2005-08-31 | — | — | EP | claimed |
| WO-2005065681-A1 | N- HYDROXY-3-(3-(1H-IMIDAZOL-2-YL)-PHENYL)-ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HISTONE DEACETYLASE (HDAC) INHIBITORS FOR THE TREATMENT OF CANCER | TAKEDA SAN DIEGO, INC. (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050159470-A1 | Histone deacetylase inhibitors | SYRRX, INC. | 2005-07-21 | — | — | US | claimed |
| US-20020165232-A1 | Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | SIKORSKI JAMES A (US) | 2002-11-07 | — | — | US | claimed |
| CN-1361207-A | Producing method of reactive dye, copolymer for lens and lens produced therefrom | HOYA CORP (JP) | 2002-07-31 | — | — | CN | claimed |
| US-6423740-B1 | ANTICARCINOGENIC AGENTS | INDENA S.P.A. (IT) | 2002-07-23 | — | — | US | claimed |
| EP-0243959-B1 | SUBSTITUTED BENZAMIDE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Dainippon Pharmaceutical Co., Ltd. (JP) | 1992-08-19 | — | — | EP | claimed |
| EP-0304190-B1 | (ARYLSULPHONYL)NITROMETHANES, PROCESS FOR THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-07-08 | — | — | EP | claimed |
| US-5102905-A | For treating side effects of diabetes and galactosemia | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-04-07 | — | — | US | claimed |
| CN-1037339-A | Heterogeneous ring compound | ICI PLC (GB) | 1989-11-22 | — | — | CN | claimed |
| EP-0340010-A2 | Heterocyclic nitromethane derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-11-02 | — | — | EP | claimed |
| US-4870074-A | Substituted benzamide derivatives, for enhancing gastrointestinal motility | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1989-09-26 | — | — | US | claimed |
| CN-1031529-A | Pharmaceutical composition | ICI PLC (GB) | 1989-03-08 | — | — | CN | claimed |
| EP-0243959-A1 | Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | Dainippon Pharmaceutical Co., Ltd. (JP) | 1987-11-04 | — | — | EP | claimed |
| US-4138411-A | RUTHENIUM OR OSMIUM CATALYST | RHONE-POULENC S. A. (FR) | 1979-02-06 | — | — | US | claimed |
| US-4085135-A | ANTIULCER | TAISHO PHARMACEUTICAL CO., LTD. (JA) | 1978-04-18 | — | — | US | claimed |